TFRC and rheumatoid arthritis: Studies on targeting Tfh and Tfr cells revealed that CTLA-4-Ig, iguratimod, abatacept, low-dose IL-2, and alcohol consumption could ameliorate RA by inhibiting Tfh cell responses and restoring the Tfr/Tfh balance (102–107).